18-Month Interim Results of a Registry Study To Establish Long-Term Safety and Pharmaco-Economic Data on Fingolimod (Gilenya®) in Multiple Sclerosis Patients in Germany (PANGAEA)

被引：0
|
作者：
Ziemssen, Tjalf [1 ]
Lorente, Maria Diaz [2 ]
Vollmar, Patrick [2 ]
Meergans, Matthias [3 ]
Tracik, Ferenc Mark [2 ]
Kempcke, Raimar [4 ]
van Lokven, Tom [2 ]
机构：
[1] Univ Clin Dresden, MS Ctr, Dresden, Germany
[2] Novartis Pharma GmbH, Nurnberg, Germany
[3] Novartis Pharma GmbH, Basel, Switzerland
[4] Univ Clin Dresden, Dresden, Germany
来源：
NEUROLOGY | 2013年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P01185
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Long-Term Effectiveness, Safety and Tolerability of Fingolimod in Patients with Multiple Sclerosis in Real-World Treatment Settings in France: The VIRGILE Study
    Papeix, Caroline
    Castelnovo, Giovanni
    Leray, Emmanuelle
    Coustans, Marc
    Levy, Pierre
    Visy, Jean-Marc
    Kobelt, Gisela
    Lamy, Fabienne
    Allaf, Bashar
    Heintzmann, Francois
    Chouette, Isabelle
    Raponi, Eric
    Durand, Barbara
    Grevat, Emmanuelle
    Kamar, Driss
    Debouverie, Marc
    Lebrun-Frenay, Christine
    NEUROLOGY AND THERAPY, 2022, 11 (02) : 633 - 658
  • [22] Long-Term Effectiveness, Safety and Tolerability of Fingolimod in Patients with Multiple Sclerosis in Real-World Treatment Settings in France: The VIRGILE Study
    Caroline Papeix
    Giovanni Castelnovo
    Emmanuelle Leray
    Marc Coustans
    Pierre Levy
    Jean-Marc Visy
    Gisela Kobelt
    Fabienne Lamy
    Bashar Allaf
    François Heintzmann
    Isabelle Chouette
    Eric Raponi
    Barbara Durand
    Emmanuelle Grevat
    Driss Kamar
    Marc Debouverie
    Christine Lebrun-Frenay
    Neurology and Therapy, 2022, 11 : 633 - 658
  • [23] Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma (aBCC): 18-month update of the pivotal ERIVANCE BCC study
    Sekulic, Aleksandar
    Migden, Michael R.
    Basset-Seguin, Nicole
    Garbe, Claus
    Gesierich, Anja
    Lao, Christopher D.
    Miller, Chris
    Mortier, Laurent
    Murrell, Dedee F.
    Hamid, Omid
    Quevedo, Fernando
    Schadendorf, Dirk
    Hou, Jeannie
    Yue, Huibin
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [24] Long-term safety and efficacy of teriflunomide in patients with relapsing multiple sclerosis: Results from the TOWER extension study
    Miller, Aaron E.
    Olsson, Tomas P.
    Wolinsky, Jerry S.
    Comi, Giancarlo
    Kappos, Ludwig
    Hu, Xueqiang
    Xu, Xianhao
    Lublin, Alex L.
    Truffinet, Philippe
    Chavin, Jeffrey
    Delhay, Jean-Luc
    Benamor, Myriam
    Purvis, Annie
    Freedman, Mark S.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 46
  • [25] Long-term efficacy of fingolimod in patients with relapsing remitting multiple sclerosis: results from the phase 3 FREEDOMS II extension study
    Reder, A. T.
    Jeffery, D.
    Goodin, D.
    Kappos, L.
    Lublin, F. D.
    Radue, E. W.
    Rammohan, K.
    Vollmer, T.
    Agius, M. A.
    Stites, T.
    Li, B.
    Cappiello, L.
    von Rosenstiel, P.
    Calabresi, P. A.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 510 - 511
  • [26] Long-term (>7-year) efficacy and safety data from a phase II extension study of fingolimod in relapsing multiple sclerosis
    Montalban, X.
    Comi, G.
    Antel, J.
    O'Connor, P.
    de Vera, A.
    Cremer, M.
    Sfikas, N.
    Francis, G.
    Kappos, L.
    JOURNAL OF NEUROLOGY, 2012, 259 : S69 - S70
  • [27] Long-term efficacy, safety and tolerability with fingolimod treatment in patients with multiple sclerosis in real-world settings in France: three-year results of the VIRGILE study
    Lebrun-Frenay, C.
    Papeix, C.
    Kobelt, G.
    Visy, J. M.
    Coustans, M.
    Debouverie, M.
    Lamy, F.
    Durand, B.
    Chouette, I.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 698 - 699
  • [28] Long-Term Safety and Tolerability of Fentanyl Buccal Tablet for the Treatment of Breakthrough Pain in Opioid-Tolerant Patients with Chronic Pain An 18-Month Study
    Fine, Perry G.
    Messina, John
    Xie, Fang
    Rathmell, James
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2010, 40 (05) : 747 - 760
  • [29] Long-term safety profile of fingolimod in the treatment of multiple sclerosis: Results of the 'DIAMOND' non-interventional, prospective, observational study conducted in the routine care of Greece
    Mitsikostas, D. D.
    Zafeiropoulou, E.
    Dardiotis, E.
    Orologas, A.
    Mastorodimos, V.
    Markakis, I.
    Karageorgiou, K.
    Grigoriadis, N.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 893 - 893
  • [30] Safety profile of BG-12 (dimethyl fumarate) in relapsing remitting multiple sclerosis: long-term interim results from the ENDORSE extension study
    Phillips, J. T.
    Fox, R. J.
    Selmaj, K.
    Yang, M.
    Zhang, R.
    Novas, M.
    Sweetser, M. T.
    Viglietta, V.
    Gold, R.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 457 - 457
12345